Careers  |  Sign In  |  Register

Researchers Discover Potential New Treatment for HIV

Bloomberg News reports that two new studies published in Nature may offer a promising new treatment for HIV-infected patients. In the first study researchers injected a single dose of monoclonal antibody derived from the blood of HIV-infected people into “rhesus monkeys chronically infected with the pathogenic simian–human immunodeficiency virus SHIV-SF162P3.” Researchers found that a single dose of antibodies reduced HIV infection to undetectable levels and that infection levels remained so for almost two months. In the second study, researchers injected two separate antibodies and found that while each one did not efficiently keep HIV infection numbers low for longer than 1 week, when the antibodies were administered together, they suppressed the virus for as long as five weeks. Researchers believe the “findings of these two papers could revolutionize efforts to cure HIV.”

Read the article published by Bloomberg News.

Read the first study in Nature.

Read the second study in Nature.